Flu vaccine showdown: which type wins?
NCT ID NCT05479370
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study tested three different flu vaccines—made using eggs, cells, or recombinant technology—in 366 adults to see which triggers the strongest immune response. The goal is to find if newer manufacturing methods offer better protection, especially against certain flu strains. Participants gave blood samples over nearly a year to measure antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Centre for Infectious Diseases (NCID)
Singapore, Singapore, 308442, Singapore
Conditions
Explore the condition pages connected to this study.